Braskem Schedules EGM to Formalize New Governance Post-Control Change
BAK sits 93% above its 52-week low of $2.32.
Summary
Braskem announced an Extraordinary General Meeting (EGM) on June 8, 2026, to approve significant bylaw amendments and elect a new Board of Directors, formalizing the governance structure under the recently established Shareholders' Agreement.
Key Events · Corporate Governance and Compliance · BAK
-
EGM Postponed and Rescheduled
The Extraordinary General Meeting (EGM) originally set for May 28, 2026, has been postponed and is now scheduled for June 8, 2026, to be held digitally.
-
Significant Bylaw Amendments Proposed
The EGM agenda includes extensive amendments to the company's bylaws to reflect the new Shareholders' Agreement and implement new governance practices, including changes to the Board of Directors and Executive Board composition and operation, and making several committees statutory.
-
New Board of Directors Election
Shareholders will vote on the election of new members to the Company's Board of Directors, a key step in formalizing the new control structure.
-
Executive Board Term Alignment
The Board of Directors will be authorized to anticipate the end of the current Executive Board's term and begin a new two-year term, aligning it with the newly elected Board of Directors.
Analysis · BAK · Industrial Applications And Services
This Extraordinary General Meeting (EGM) is a critical step in implementing the new governance structure following the recent change in control, specifically the sale of Novonor's stake and the new Shareholders' Agreement with Shine I Fund and Petrobras. The proposed bylaw amendments, board elections, and executive term alignment are essential for establishing stable leadership and operational clarity as the company navigates significant financial challenges, including a substantial net loss and consideration of judicial reorganization.
At the time of this filing, BAK was trading at $4.47 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $2.32 to $5.40. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.